Section Arrow
JSPR.NASDAQ
- Jasper Therapeutics
Quotes are at least 15-min delayed:2025/01/11 17:21 EST
Last
 7.05
+0.06 (+0.86%)
Day High 
7.43 
Prev. Close
6.99 
1-M High
23.37 
Volume 
2.46M 
Bid
6.65
Ask
7
Day Low
6.5713 
Open
7.12 
1-M Low
6.81 
Market Cap 
104.86M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 19.47 
20-SMA 20.54 
50-SMA 21.65 
52-W High 31.01 
52-W Low 6.81 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-4.75/-6.32
Enterprise Value
106.67M
Balance Sheet
Book Value Per Share
5.58
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
CDTConduit Pharmaceuticals0.1233+0.0413+50.37%-- 
MRSNMersana Therapeutics0.72-0.58-44.62%-- 
TNXPTonix Pharmaceuticals Holding Corp.0.2787+0.0227+8.87%-- 
ZVSAZyVersa Therapeutics1.47+0.29+24.58%0PE
SANASana Biotechnology3.66-0.64-14.88%-- 
Quotes are at least 15-min delayed:2025/01/11 17:21 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.